E I du Pont de Nemours & Company (DD)

DD (NYSE:Chemicals)
$65.95
neg -0.21
-0.32%
Today's Range: 65.87 - 66.21 | DD Avg Daily Volume: 3,833,600
Last Update: 08/27/14 - 10:51 AM EDT
Volume: 370,017
YTD Performance: 1.83%
Open: $65.96
Previous Close: $66.16
52 Week Range: $56.09 - $69.75
Oustanding Shares: 915,242,000
Market Cap: 60,543,258,300
6-Month Chart
TheStreet Ratings Grade for DD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 5 5
Moderate Buy 0 0 0 0
Hold 10 10 9 9
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.53 2.53 2.40 2.40
Latest Dividend: 0.47
Latest Dividend Yield: 2.84%
Dividend Ex-Date: 08/13/14
Price Earnings Ratio: 20.93
Price Earnings Comparisons:
DD Sector Avg. S&P 500
20.93 20.70 28.88
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.85% 14.92% 43.55%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.80 0.10 0.03
Net Income 72.80 -0.06 -0.02
EPS 75.60 0.57 0.16
Earnings for DD:
EBITDA 9.20B
Revenue 35.96B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.53 $0.72 $4.01 $4.66
Number of Analysts 11 10 14 15
High Estimate $0.55 $0.78 $4.05 $5.15
Low Estimate $0.51 $0.64 $3.93 $4.16
Prior Year $0.45 $0.59 $3.88 $4.01
Growth Rate (Year over Year) 18.38% 21.69% 3.44% 16.11%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
It's time to start buying selectively during the pullback.
Bearish
Jul 23, 2014 | 8:02 AM EDT
DD was downgraded from Overweight to Neutral, JP Morgan said. Estimates also lowered due to reduced cash flow from the Agricultura...

This Morning's Market Setup Real Money Pro($)

Where it began.
Here's what these pops and drops appear to signify.

DuPont Takes a Beating Real Money Pro($)

I believe it's headed for the low $60s -- though very patient bulls may ultimately be rewarded.
If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.
Staying on the right side is one of the most important, and simplest, elements of trading.
Don't chase the market after rallies. Do buy into periods of weakness.
Maybe you don't truly want a long-term 'patient portfolio' and all that that entails -- and that's OK.
Update
May 08, 2014 | 7:07 AM EDT
Wells Fargo Industrial & Construction Conference (Day 2 of 2) - 05/07/14 - 05/08/14 New York City, NY

Columnist Conversations

I have always believed you lose the money during the bubbles through the misallocation of resources and do the...
Lang:
Thanks to Paul, Antonia and Skip -- superb and very thoughtful replies(would like to hear more). You all make...
still a good read, some 25 yr since it was published is wm. greider's "secrets of the temple" (how the fed run...
It never ceases to amaze us how reliable the broad market is during holiday trading. The lack of volume has a...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.